Neurophysiological Correlates of Neuroanatomical Dimensions in Major Depressive Disorder: Electroencephalographic Markers of Brain Function and Treatment Outcome

Read full text
Authors: Wenyi Xiao, Rachel D. Woodham, Mathilde Antoniades, Dhivya Srinivasan, Yong Fan, Güray Erus, Jose Angel Fernández García, Stephen R. Arnott, Taolin Chen, Ki Sueng Choi, Cherise Chin Fatt, Benicio Noronha Frey
+38 more Faranak Farzan, Vibe G. Frøkjær, Melanie Ganz, Beata R. Godlewska, Stefanie Hassel, Keith T. Ho, Andrew Mark McIntosh, Kun Qin, Susan Rotzinger, Matthew D. Sacchet, Jonathan B. Savitz, Haochang Shou, Ashish Singh, Aleks Stolicyn, Irina A. Strigo, Stephen C. Strother, Duygu Tosun, Dongtao Wei, Roland Zahn, Ian Muir Anderson, W. Edward Craighead, J.F.W. Deakin, Boadie Waid Dunlop, Rebecca M. Elliott, Qiyong Gong, Ian H. Gotlib, Catherine J. Harmer, Sidney H. Kennedy, Gitte M. Knudsen, Helen S. Mayberg, Martin P. Paulus, Jiang Hua Qiu, Madhukar H. Trivedi, Heather Clare Whalley, Chao‐Gan Yan, Allan Hunter Young, Christos A. Davatzikos, Cynthia H.Y. Fu
Cited by: 0
References: 52

Abstract

Abstract Major depressive disorder (MDD) is a heterogeneous disorder with variable treatment responses and no established biomarkers for identification or predictors of treatment response. In the COORDINATE-MDD consortium, a data-driven classification identified two neuroanatomic-based dimensions: Dimension 1 (D1), with preserved grey and white matter volumes, and Dimension 2 (D2), with widespread reductions. Here, we investigated whether resting-state electroencephalography (EEG) features differ between these dimensions and whether such features predict treatment response. Participants were 237 MDD (155 women; mean age 37.47 ± 13.36 year) from two clinical trials: CAN-BIND (escitalopram) and EMBARC (randomized to sertraline or placebo). All were medication-free at baseline, in a current depressive episode of at least moderate severity. Resting-state, eyes-closed EEG was recorded at baseline. EEG features included spectral power, frontal alpha asymmetry (FAA), multiscale sample entropy (MSE), and inter-site phase clustering (ISPC). Analyses examined effects of neuroanatomical dimension (D1, D2) and clinical outcome (responder, non-responder), using ANCOVA and threshold-free cluster enhancement (TFCE). D1 participants showed greater absolute and log-transformed theta, alpha, and beta power, and lower relative delta power compared to D2, particularly in frontal and central regions. Among responders, D1 showed higher alpha and theta power and greater MSE at coarse time scales. Individuals with preserved neuroanatomy in D1 exhibit electrophysiological markers of more flexible and integrated brain function, possibly reflecting efficient top-down regulation and adaptive neural dynamics. In contrast, the D2 dimension, marked by lower complexity and elevated delta activity, may reflect disrupted network integrity, reduced cortical arousal, and impaired information processing.

Fields of Study & Subjects

Functional Brain Connectivity Studies Treatment of Major Depression Heart Rate Variability and Autonomic Control

Publication details

Journal / source
Biological Psychiatry Global Open Science
Volume
6
Issue
5
Pages
100750–100750
Publication date
7 May 2026
Language
EN